$16.21
-0.90-5.26%
Last update: Nov 5, 4:18 PM
Aurinia Pharmaceuticals Inc
AUPHNASDAQ
The average analyst price target for Aurinia Pharmaceuticals is $16.14, 1.1% below the current price. Of 6 analysts, 4 rate it Buy and 2 Hold. Targets range from $10 to $21. The latest change came on Nov 2, 2026, when RBC Capital raised its price target on Aurinia Pharmaceuticals from $16 to $18 and kept a Sector Perform rating.
Price Target Range — 6 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
